Botulinum toxin for drooling in Parkinson’s disease

Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson’s disease.

Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson’s disease.

This is a protocol.

Share/Save